baber/WOPTO huggingface dataset:
Patent CA-2667402-A1 (CA)
Title: Extrusion die
Inventor: REIFFERSCHEID MARKUS
IPC: B22D11/059
Filed: 2007-10-18
Abstract: The invention relates to an extrusion die having mold plates surrounding the casting cross-section, in which cooling canals extend, wherein the mold plates are connected to a water box by means of screw elements, and the screw elements are made of securing bolts having a threaded shaft, which can be screwed into securing threads in the mold plate. In order to achieve uniform cooling in such an extrusion die, the securing threads with the longitudinal center axes thereof are each disposed such that they extend between two adjacent coolant channels, wherein the diameter of each threaded bore is larger than the distance between two adjacent cooling channels, and the bores for the securing threads end at a distance to the bottom of the cooling channels, limiting the screw-in depth of the securing bolts.
Patent CA-2671164-A1 (CA)
Inventor: EPPIG CHRISTOPHER P
IPC: C10B57/12
Filed: 2007-11-15
Abstract: An improved fluidized coking process wherein an effective amount of a basic material, preferably an alkali or alkaline-earth metal-containing compound, is added to the coking zone to mitigate agglomeration of the coke during the coking of a heavy hydrocarbonaceous feedstock to produce lower boiling products.
Patent CA-2671974-A1 (CA)
Inventor: NIKOLIC SERJAN D
IPC: A61N1/05
Filed: 2007-12-13
Abstract: Devices and methods are descnbed herein which are directed to the treatment of a patient's heart having, or one which is susceptible to heart failure, to improve diastolic function, by implanting a multiply-.pi.bbed diastolic recoil device, which may or may not additionally compnse a membrane, within a vent.pi.cle of the heart The device may be anchored to said wall by means of said .pi.bs, and may further comprise an atraumatic central hub, spacing said .pi.bs from the bottom of said vent.pi.cle The device may provide an elastic recoil force to said walls of said vent.pi.cle du.pi.ng diastole in order to improve ejection fraction, augment movement of said walls, decrease stress in said walls, reduce diastolic pressure of said vent.pi.cle, assist in expansion of said vent.pi.cle, or support a weakened cardiac wall Said membrane may seal against said walls, thereby decreasing ventricular volume and pressure
Patent CA-2672291-A1 (CA)
Inventor: LINDGREN ANDERS
IPC: H04L67/54
Filed: 2006-12-14
Abstract: A method and arrangement for withholding notifications with client data of an observed client (B) to a watching client (A) having an ongoing subscription for receiving the notifications from a client data server (502). In response to a subscription suspend trigger (5:1), the watching client sends a subscription suspend message (5:2,5:3) to the client data server indicating that client data notifications should be temporarily withheld while retaining said subscription. In response to receiving a subscription resume trigger (5:5), the watching client then sends a subscription resume message (5:6,5:7) to the client data server indicating that client data notifications should be delivered again. The watching client will then receive client data notifications (5:8) according to the retained subscription.
Patent CA-2673189-A1 (CA)
Title: Extruded legumes
Inventor: BERRIOS JOSE DE J
IPC: A23L5/40
Filed: 2007-12-18
Abstract: An extrusion process for producing a uniform and highly expanded food product is disclose The uniform expansion ratio possessed by the extruded product provides a consistent texture an has application in a wide variety of food consumables, ranging from snacks to breakfast cereals.
Patent CA-2673748-A1 (CA)
Title: Transgenic plant event detection
Inventor: LEUNDA AMAYA
IPC: C12Q1/68
Filed: 2008-01-29
Abstract: The present invention relates to detection of materials derived from transgenic plant events. Inparticular, the invention provides methods, reagents, kits and reference materials for detecting the presence or absence in a sample of genetic material derived from and attributable to select transgenic plant events.
Patent CA-2673763-A1 (CA)
Inventor: MIKI ISAO
IPC: G07D9/00
Filed: 2006-12-25
Abstract: A banknote processing device has, besides cassettes (16a-16f) where banknotes dispensed in normal dispensing are received, a bait money receiving section (14) for receiving bait money as emergency banknotes that are to be dispensed in an emergency. When dispensing of the bait money is requested in an emergency, the bait money is forcibly conveyed from the bait money receiving section (14) to a banknote dispensing opening to immediately dispense the bait money.
Patent CA-2675825-A1 (CA)
Inventor: HASSAN AZIZ
IPC: B01F27/93
Filed: 2008-06-24
Abstract: A method for hydrodesulfurization by forming a dispersion comprising hydrogen-containing gas bubbles with a mean diameter of less than 1 micron dispersed in a liquid phase comprising sulfur-containing compounds. Desulfurizing a liquid stream comprising sulfur-containing compounds by subjecting a fluid mixture comprising hydrogen-containing gas and the liquid to a shear rate greater than 20,000 s-1 to produce a dispersion of hydrogen in a continuous phase of the liquid and introducing the dispersion into a fixed bed hydrodesulfurization reactor from which a reactor product is removed. Systems of apparatus for hydrodesulfurization are also presented.
Patent CA-2676353-A1 (CA)
Title: Production of rosmarinic acid from spearmint and uses thereof
Inventor: FLETCHER RON
IPC: A23L27/10
Filed: 2008-01-23
Abstract: The present invention provides plants and plant tissues of spearmint (Mentha spicata) with enhanced rosmarinic acid levels, and extracts derived there from. Methods and compositions for production and use of rosmarinic acid from spearmint as a nutraceutical are also provided. In particular, an edible beverage derived from plant tissues of spearmint that comprise more than 77.5 mg/g rosmarinic acid on a dry weight basis, is provided, as well as methods for making such a beverage and for using it to treat an inflammatory or infectious disease.
Patent CA-2677065-A1 (CA)
Title: Methods and systems for combined cyclic delay diversity and precoding of radio signals
Inventor: JOENGREN GEORGE
IPC: H04B7/06
Filed: 2008-02-12
Abstract: In a transmitter or transceiver, signals can be precoded by multiplying symbol vectors with various matrices. For example, symbol vectors can be multiplied with a first column subset of unitary matrix (518) which spreads symbols in the symbol vectors across virtual transmit antennas, a second diagonal matrix (516) which changes a phase of the virtual transmit antennas, and a third precoding matrix (515) which distributes the transmission across the transmit antennas.
Patent CA-2677158-A1 (CA)
Inventor: CAVE CHRISTOPHER R
IPC: H04B7/005
Filed: 2008-02-04
Abstract: L'invention concerne un procédé et un appareil pour ajuster des autorisations de puissance dans des communications sans fil. De multiples tables d'autorisation de puissance sont stockées, et une ou plusieurs tables sont désignées pendant une communication.
Patent CA-2677798-A1 (CA)
Title: Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
Inventor: ZHAO HONG
IPC: A61K31/33
Filed: 2008-02-08
Abstract: A method of treating a resistant or refractory cancer in a mammal includes administering an effective amount of a compound of to the mammal. In preferred aspects, the cancer is resistant or refractory to CPT-1 1 or CPT therapy.
Patent CA-2680033-A1 (CA)
Title: Systems and methods of providing proxy-based quality of service
Inventor: PLAMONDON ROBERT
IPC: H04L47/27
Filed: 2008-03-11
Abstract: Systems and methods for dynamically controlling bandwidth of connections are described. In some embodiments, a proxy for one or more connections may allocate, distribute, or generate indications of network congestion via one or more connections in order to induce the senders of the connections to reduce their rates of transmission. The proxy may allocate, distribute, or generate these indications in such a way as to provide quality of service to one or more connections, or to ensure that a number of connections transmit within an accepted bandwidth limit. In other embodiments, a sender of a transport layer connection may have a method for determining a response to congestion indications which accounts for a priority of the connection. In these embodiments, a sender may reduce or increase parameters related to transmission rate at different rates according to a priority of the connection.
Patent CA-2680199-A1 (CA)
Title: Liquid filter assembly
Inventor: ASSION NORBERT M
IPC: B01D24/00
Filed: 2008-03-18
Abstract: A liquid filter assembly including a first liquid filter; a second different liquid filter element; a housing and a relief valve. The liquid filter assembly forms a first liquid flow path having the first liquid filter element therein, and a second liquid flow path having the second liquid filter element therein. The first liquid filter element forms a mixing chamber in a center of the first liquid filter element for mixing the liquid filtered by the first liquid filter element and the liquid filtered by the second liquid filter element. The relief valve is configured to allow liquid to bypass the second liquid flow path to mix with liquid filtered by the first liquid filter element in the mixing chamber.
Patent CA-2680568-A1 (CA)
Inventor: KERVINEN JARI
IPC: E05B15/10
Filed: 2008-04-09
Abstract: A door lock with a bolt, wherein the bolt pieces of the dual-action bolt are prevented from turning away from each other as the bolt pieces have two projections (24, 26) arranged to cooperate with the inner surface (30) of the front plate. In relation to the support of the bolt piece on the shaft (29), one of the projections (26) is arranged on the opposite side in the axial direction compared to the other away-facing projection.
Patent CA-2681155-A1 (CA)
Inventor: WELLS MICHAEL C
IPC: A61M35/00
Filed: 2009-04-23
Abstract: A non-invasive tissue oxygenation system for accelerating the healing of damaged tissue and to promote tissue viability is disclosed herein. The system is comprised of a lightweight portable electrochemical oxygen concentrator, a power management system, microprocessors, memory, a pressure sensing system, an optional temperature monitoring system, oxygen flow rate/oxygen partial pressure monitoring and control system, a display screen and key pad navigation controls as a means of providing continuous variably controlled low dosages of oxygen to a wound site and monitoring the healing process. A kink resistant oxygen delivery tubing, whereby the proximal end is removably connected to the device and the distal end with holes or a flexible, flat, oxygen-permeable tape is positioned at or near the wound bed as a means of applying near 100% pure oxygen to the wound site. The distal end of the tube is in communication with the electrochemical oxygen concentrator and wound monitoring system to communicate oxygen partial pressure and, where appropriate, temperature information. A moisture absorbent dressing is positioned over the distal end of the tubing at the wound site and a reduced moisture vapor permeable dressing system is positioned whereby covering the moisture absorbent dressing, distal end of tubing and wound site creating a restricted or occluded airflow enclosure. The restricted airflow enclosure allows the out-of-the-way control and display unit to provide a controlled hyperoxia and hypoxia wound site for accelerated wound healing.
Patent CA-2684488-A1 (CA)
Title: Biomarker normalization
Inventor: SULLIVAN BENJAMIN
IPC: G01N13/04
Filed: 2008-04-16
Abstract: In accordance with the invention, a fluid sample is measured with a tear film measuring system that includes a processing device that receives a sample chip comprising a sample region configured to contain an aliquot volume of sample fluid, the processing device configured to perform analyses of osmolarity and of one or more biomarkers within the sample fluid, wherein the analysis of biomarkers includes normalization of biomarker concentration values.
Patent CA-2684561-A1 (CA)
Inventor: AZUMA MITSUYOSHI
IPC: A61K31/4468
Filed: 2008-04-18
Abstract: Provided are an agent for promoting ocular tissue neuritogenesis promoter and a pharmaceutical use of the promoter. An agent for promoting ocular tissue neuritogenesis, containing N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide or a pharmaceutically acceptable salt thereof, and an agent for promoting corneal neuritogenesis and retinal neuritogenesis, containing N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide or a pharmaceutically acceptable salt thereof. The corneal neuritogenesis promoter of the present invention is used for the improvement of corneal sensitivity, treatment of dry eye, or treatment of a corneal epithelial disorder. The retinal neuritogenesis promoter of the present invention is used for the improvement of a visual dysfunction.
Patent CA-2685058-A1 (CA)
Inventor: BEALS WILLIAM MICHAEL
IPC: G06F21/02
Filed: 2008-05-08
Abstract: Various embodiments described herein relate to apparatus for executing software in a secure computing environment (100), A secure processor (104) can be used and configured to request a context swap from s first context to a second context when switching execution from a first portion of software to a second portion of software, A context manager (106), which can be in communication with the secure processor, can be configured to receive and initials a requested context swap, A trust vector verifier (108), which can be in communication with the secure processor and the context manager, can be configured to load a trust vector descriptor upon command from a context manager.
Patent CA-2686180-A1 (CA)
Title: Shipping container systems
Inventor: SIMS DAVID M
IPC: B65D88/22
Filed: 2009-11-17
Abstract: The application relates to shipping container systems that include a large multi--layered flexible container ("flexitank") disposed inside a large rigid shipping container which has an open end with one or more doors capable of an open or closed position, and further including one or more bulkhead assemblies, one of the bulkhead assemblies interposed between the flexitank and the open end of the rigid container and/or the doors. In at least one specific embodiment, the bulkhead assembly includes a first brace disposed vertically along a portion of the first side wall inner surface; a second brace disposed vertically along a portion of the second side wall inner surface; and a bulkhead panel member extending horizontally between the first brace and the second brace. In other embodiments, bulkhead assemblies may utilize generally curved or "swept" bulkhead bars, which do not require vertical braces.
Patent CA-2687114-A1 (CA)
Inventor: WAMPLER RICHARD
IPC: A61M1/10
Filed: 2007-05-31
Abstract: A heart assist device comprising a rotary pump housing having a cylindrical bore, a pumping chamber and a motor stator including an electrically conductive coil located within the housing and surrounding a portion of the cylindrical bore. A rotor has a cylindrical shaft, at least one impeller appended to one end of the shaft, and a plurality of magnets located within the shaft. The rotor shaft is positioned within the housing bore with the magnets opposite the motor stator, and the impeller is positioned within the pumping chamber. The housing bore is closely fitted to the outer surface of the shaft forming a hydrodynamic journal bearing, with the pumping chamber and journal bearing connected by a leak path of blood flow between the pumping chamber and the journal bearing. A backiron of the motor stator attracts the rotor magnets to resist longitudinal displacement of the rotor within the housing during operation. The relative orientation of positions of the inflow, outflow, and leakage flow paths may be varied within the pump, such as to accommodate different intended methods for implantation and/or use.
Patent CA-2687705-A1 (CA)
Inventor: WELLER HANS-MICHAEL
IPC: B23B31/12
Filed: 2009-12-08
Abstract: A clamping device has several clamping element receptacles each with a clamping element held by the clamping element receptacle. The clam-ping element receptacles have an inclination running obliquely to a clam-ping direction of the clamping device and by means of which the clam-ping element is guided. The clamping element has a clamping jaw sup-port and the clamping jaw is connectable to the clamping jaw support.  The clamping jaw engages in an undercut provided on the clamping jaw support and is additionally fixed by means of a positive fixing means to the clamping jaw support when it is connected to the clamping jaw sup-port.
Patent CA-2691473-A1 (CA)
Inventor: CINK JAMES H
IPC: A01M17/00
Filed: 2008-06-27
Abstract: In a method of monitoring and/or controlling termite populations in an area accessible to the termites a wood that has been heat-treated to a temperature of greater than about 150 degrees C  (302 degrees F), in solid or particulate form, is located in the area and monitored. A toxic bait may also be located in the area. In another method, a toxic bait that contains a toxicant and wood that has been heat-treated to a temperature of at least about 150 degrees C (302 degrees F) may be located in the area. In another method, an extract that is extracted from such heat treated wood and in the form of a liquid or a solid/particulate is located in the area to be monitored.
Patent CA-2695179-A1 (CA)
Inventor: STROUMPOULIS DIMITRIOS
IPC: C08B37/08
Filed: 2008-07-24
Abstract: The present invention relates to biocompatible crosslinked hyaluronic acid gel compositions, methods of their manufacture and use, and the crosslinkers used to make them. In one aspect of the invention, a polyethylene glycol crosslinking agent is described for crosslinking hyaluronic acid preferably a multifunctional one like 4-Arm Star PEG. In another aspect of the invention, crosslinking agents comprising more than two functional groups are described. These multifunctional crosslinking agents can be used on their own to crosslink hyaluronic acid, or they may be combined with bifunctional crosslinking agents in varying ratios to make hyaluronic acid of tunable mechanical strength and hardness. The present invention also discloses hyaluronic acid compositions that have been coated with polyethylene glycol and methods of their use.
Patent CA-2696815-A1 (CA)
Inventor: NAKA TAKEHIRO
IPC: G06F19/00
Filed: 2008-07-16
Abstract: This invention improves accuracy of lightning strike simulation. There is provided a lightning strike simulation apparatus including a storage device (11) for storing lightning strike data, a setting unit (12) for setting a simulation target and the like in a simulation space, a downward leader advancing unit (13) for advancing a downward leader from a lightning strike start position set by the setting unit (12), an upward leader advancing unit (14) for advancing upward leaders from lightning strike-receiving candidate points set in the simulation space when a distance between a leading edge of the downward leader and a reference point is within a first threshold value, and a lightning strike point determination unit (15) for, when a distance between a leading edge of the downward leader and a leading edge of any one of the upward leaders is within a second threshold value, determining that the lightning strike--receiving candidate point corresponding to the any one of the upward leaders is a lightning strike point.
Patent CA-2696999-A1 (CA)
Inventor: OBREJANU MARCEL
IPC: F17D1/08
Filed: 2008-10-01
Abstract: The invention concerns a section of tubing or other conduit having a flow passage. The flow passage extends through the tubing and incorporates a member extending through the passage and guides which constrain a fluid flowing through the flow passage to flow around the member along a path which is longer than an axial length of the flow passage in a fluid flow direction. The guides may define an annular path. The conduit may comprise an inside wall and the guides may comprise a combination of at least one spiral channel defined along the inside wall and the member may be a sucker rod extending along the flow passage.
Patent CA-2697304-A1 (CA)
Inventor: WIMMER ECKHARD
IPC: B66C23/70
Filed: 2008-08-29
Abstract: The invention relates to a crane jib for a crane, having a longitudinal axis and an imaginary contour line that extends in a transversal plane relative to an axis of symmetry (s) in an at least approximately mirror-symmetric manner, the contour line intersecting the axis of symmetry (s) in a first and a second point of intersection (S1, S2) and the contour line having an extremal point (E) with a maximum distance (e) from the axis of symmetry (s) between the first point of intersection (S1) and a center (M) that is equally interspaced from the first and the second point of intersection (S1, S2). The distance (d) of the contour line from the axis of symmetry (s) is smaller or equal 0.8 times the maximum distance (e) at approximately a fourth of the distance (D) between the first and the second point of intersection (S1, S2), starting from the second point of intersection (S2).
Patent CA-2699142-A1 (CA)
Inventor: HABIB WALID
IPC: A61K9/50
Filed: 2008-03-19
Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
Patent CA-2701170-A1 (CA)
Inventor: WILLIAMS TIMOTHY JAMES
IPC: A01K67/027
Filed: 2008-11-26
Abstract: A composition and method is provided for modifying sperm fertility in mammals for the purpose of biasing the gender in favor of male offspring. The composition includes an amount of a class of compounds of phenoxazine or phenothiazine, having the structure (FIG.1) and ionic derivatives thereof, wherein R1 is H, a lower alkyl group or N(R3)2, R2 is N, S, O, and R3 is H  or a lower alkyl group. A second component of the composition is an amount of a hexose sugar or the phosphorylated hexose esters of such. When mixed with living sperm prior to or at the time of insemination, the composition results in modified rates of conception and an alteration of the birth sex ratio mammals.
Patent CA-2701291-A1 (CA)
Inventor: KANNAN RANGARAMANUJAM M
IPC: A61K47/48
Filed: 2008-10-06
Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compo-sitions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
Patent CA-2706918-A1 (CA)
Inventor: BLATTNER FREDERICK
IPC: C12N15/66
Filed: 2008-11-26
Abstract: Provided herein is a nucleic acid comprising a mutant lac operator operably linked to a gene of interest, a host cell comprising the nucleic acid, and a method of using the host cell to express the gene of interest. Also provided is a recA-mediated cloning method.
Patent CA-2708013-A1 (CA)
Inventor: HENDERSON LEE DOUGLAS
IPC: B01J31/00
Filed: 2010-06-18
Abstract: Ketimide ligand containing catalyst/reactor continuity in a dispersed phase reaction in terms of initial activation and subsequent deactivation may be improved by treating the support with a metal salt. The activator and catalyst are then deposited on the treated support. The resulting catalyst has a lower consumption of ethylene during initiation and a lower rate of deactivation. Preferably the catalyst is used with an antistatic agent.